SCHEMBL8580811

SCHEMBL8580811

O=c1oc2ccc(O)c(O)c2c(-c2ccccc2)c1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.46
KDM4E B2RXH2 6/20 0.46
RECQL P46063 3/20 0.46
GAA P10253 3/20 0.46
POLB P06746 2/20 0.46
PKM P14618 2/20 0.46
ADORA3 P0DMS8 2/20 0.45
ADORA2A P29274 2/20 0.45
ADORA1 P30542 1/20 0.45
MEN1 O00255 7/20 0.43
KMT2A Q03164 7/20 0.43
CYP3A4 P08684 6/20 0.43
ALOX15 P16050 5/20 0.43
HSD17B10 Q99714 5/20 0.43
TP53 P04637 4/20 0.43
HPGD P15428 4/20 0.43
LMNA P02545 2/20 0.43
USP2 O75604 2/20 0.43
MAPK1 P28482 2/20 0.43
SMN1; SMN2 Q16637 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20587580 0.84 ERAP1 (0.47) MAPTKDM4ERECQLGAAPOLB
SCHEMBL1255490 0.79 MEN1 (0.48) MAPTKDM4ERECQLGAAPOLB
SCHEMBL27844788 0.76 GAA (0.52) MAPTKDM4ERECQLGAAPOLB
SCHEMBL28143419 0.76 KDM4E (0.56) MAPTKDM4EPKMMEN1KMT2A
SCHEMBL20587781 0.75 KDM4E (0.48) MAPTKDM4ERECQLGAAPOLB
Methane SCHEMBL29191891 0.74 GAA (0.50) MAPTKDM4ERECQLGAAPOLB
SCHEMBL9749884 0.74 LMNA (0.50) MAPTKDM4ERECQLGAAPOLB
SCHEMBL11479865 0.73 CYP3A4 (0.58) MAPTKDM4ERECQLGAAPKM
SCHEMBL471861 0.73 MEN1 (0.71) MAPTKDM4ERECQLGAAPKM
SCHEMBL5084165 0.72 ABCB1 (0.75) MAPTKDM4ERECQLPKMMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106974907-A A kind of application of 4 aryl-coumarin class compound 山东省医学科学院药物研究所 2017-07-25 CN disclosed
WO-1998025608-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING A 4-ARYLCOUMARIN FOR THE TREATMENT OF VIRAL INFECTIONS BIO'S S.R.L. (IT) 1998-06-18 WO disclosed